失效模式和影响分析在医院避光输注药品管理中的应用

目的：通过将失效模式和影响分析（FMEA）这一方法运用在我院避光输注药品管理过程中，使避光输注药品的用药风险水平显著下降。方法：通过分析和评估避光药品从入库到输注后管理过程中可能出现的失效模式，找出导致失效模式的原因，计算风险值（RPN），统计需改进的流程，提出优化方案。通过再次评估，比较改进前后RPN值，对避光药品静脉输注中的风险进行预防和控制。结果：对FMEA实施前后数据进行两样本的T检验，显示T>2.262（T 0.05，9），P<0.05，说明管理前后风险值存在显著性差异，利用FMEA管控后的风险值均比改进前明显下降。结论：运用FMEA规范我院避光输注药品的管理后，因药品使用、管理不当引起的风险大大减少。

Application of failure mode and effect analysis in light resistant infusion drugs

OBJECTIVE To prevent and control risks by applying the failure mode and effect analysis (FMEA) to the dealing process of light resistant drug infusion. METHODS The potential failure mode of light resistant drugs were analyzed and assessed from the warehouse to management after infusion, to find out the causes of failure mode, calculate the risk priority number (RPN), summarize the flow processes to be improved, propose the optimal protocol. Through assessing again and comparing RPN values before and after improvement, risks would be prevented and controlled during intravenous infusion of light resistant drugs. RESULTS Before and after performing failure mode and effects analysis (FMEA), T>2.262 (T0.05,9), P<0.05. Risk values were significantly different before and after FMEA. After using FMEA, the risk values were significantly lower than those before FMEA. CONCLUSION After using FMEA to control the risks of light resistant infusion drugs, the risk resulting from improper drug use and management is greatly reduced.